tiprankstipranks
Innovent Biologics (MX:1801N)
:1801N
Mexico Market
1801N
Innovent Biologics
RESEARCH TOOLSreports

Innovent Biologics (1801N) Ratios

1 Followers

Innovent Biologics Ratios

MX:1801N's free cash flow for Q2 2026 was ¥0.85. For the 2026 fiscal year, MX:1801N's free cash flow was decreased by ¥ and operating cash flow was ¥0.22. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.68 2.62 2.35 3.00 3.29
Quick Ratio
 2.48 2.47 2.16 2.78 2.88
Cash Ratio
 1.86 2.07 1.72 2.25 0.29
Solvency Ratio
 0.10 0.08 0.02 -0.08 -0.27
Operating Cash Flow Ratio
 1.04 1.19 0.29 0.03 -0.55
Short-Term Operating Cash Flow Coverage
 17.91 12.49 3.18 0.12 -2.16
Net Current Asset Value
¥ 4.93B¥ 4.82B¥ 1.79B¥ 5.33B¥ 4.65B
Leverage Ratios
Debt-to-Assets Ratio
 0.06 0.08 0.13 0.18 0.18
Debt-to-Equity Ratio
 0.11 0.15 0.22 0.29 0.30
Debt-to-Capital Ratio
 0.10 0.13 0.18 0.22 0.23
Long-Term Debt-to-Capital Ratio
 0.08 0.09 0.16 0.16 0.17
Financial Leverage Ratio
 2.01 1.93 1.65 1.65 1.64
Debt Service Coverage Ratio
 3.86 1.46 -1.05 -0.42 -1.78
Interest Coverage Ratio
 32.09 9.46 -11.17 -17.03 -30.71
Debt to Market Cap
 0.02 0.02 0.05 0.06 0.07
Interest Debt Per Share
 1.38 1.67 1.78 2.38 2.23
Net Debt to EBITDA
 -5.73 -11.09 9.74 9.73 -1.26
Profitability Margins
Gross Profit Margin
80.96%76.66%83.97%70.89%79.57%
EBIT Margin
12.02%5.63%-8.02%-16.85%-45.40%
EBITDA Margin
16.85%10.05%-5.10%-10.65%-38.39%
Operating Profit Margin
12.02%5.63%-8.02%-27.06%-68.54%
Pretax Profit Margin
9.82%6.43%-0.83%-18.44%-47.64%
Net Profit Margin
7.80%6.24%-1.00%-16.56%-47.83%
Continuous Operations Profit Margin
7.80%6.24%-1.00%-16.56%-47.83%
Net Income Per EBT
79.35%96.98%120.36%89.82%100.41%
EBT Per EBIT
81.73%114.35%10.40%68.15%69.50%
Return on Assets (ROA)
2.92%2.18%-0.44%-4.98%-12.39%
Return on Equity (ROE)
6.06%4.20%-0.72%-8.21%-20.31%
Return on Capital Employed (ROCE)
5.80%2.53%-4.39%-10.40%-22.16%
Return on Invested Capital (ROIC)
4.53%2.39%-4.28%-8.68%-20.81%
Return on Tangible Assets
3.03%2.27%-0.47%-4.99%-13.30%
Earnings Yield
0.84%0.69%-0.17%-1.70%-4.94%
Efficiency Ratios
Receivables Turnover
 8.19 7.44 6.01 6.17 5.00
Payables Turnover
 3.19 6.15 4.22 4.85 2.86
Inventory Turnover
 1.58 2.34 1.84 1.87 0.65
Fixed Asset Turnover
 2.93 2.40 1.67 1.33 1.12
Asset Turnover
 0.37 0.35 0.44 0.30 0.26
Working Capital Turnover Ratio
 1.06 1.34 1.27 0.73 0.55
Cash Conversion Cycle
 160.79 145.86 172.96 179.46 505.58
Days of Sales Outstanding
 44.56 49.03 60.70 59.16 73.04
Days of Inventory Outstanding
 230.73 156.17 198.71 195.56 560.20
Days of Payables Outstanding
 114.50 59.33 86.45 75.26 127.66
Operating Cycle
 275.29 205.20 259.41 254.72 633.24
Cash Flow Ratios
Operating Cash Flow Per Share
 5.60 5.78 0.79 0.09 -1.29
Free Cash Flow Per Share
 5.47 5.38 -0.26 -0.79 -2.21
CapEx Per Share
 0.13 0.39 1.05 0.89 0.93
Free Cash Flow to Operating Cash Flow
 0.98 0.93 -0.33 -8.36 1.72
Dividend Paid and CapEx Coverage Ratio
 42.34 14.64 0.75 0.11 -1.39
Capital Expenditure Coverage Ratio
 42.34 14.64 0.75 0.11 -1.39
Operating Cash Flow Coverage Ratio
 4.16 3.55 0.45 0.04 -0.59
Operating Cash Flow to Sales Ratio
 0.62 0.77 0.14 0.02 -0.42
Free Cash Flow Yield
6.45%7.86%-0.75%-2.05%-7.49%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 118.66 142.68 -591.18 -58.77 -20.23
Price-to-Sales (P/S) Ratio
 9.38 9.09 5.94 9.73 9.67
Price-to-Book (P/B) Ratio
 6.99 6.12 4.26 4.82 4.11
Price-to-Free Cash Flow (P/FCF) Ratio
 15.50 12.72 -133.71 -48.89 -13.35
Price-to-Operating Cash Flow Ratio
 15.01 11.85 43.47 408.73 -22.97
Price-to-Earnings Growth (PEG) Ratio
 19.88 -0.15 6.48 1.07 0.91
Price-to-Fair Value
 6.99 6.12 4.26 4.82 4.11
Enterprise Value Multiple
 49.94 79.39 -106.74 -81.71 -26.46
Enterprise Value
 131.18B 104.02B 51.27B 53.98B 46.29B
EV to EBITDA
 49.94 79.39 -106.74 -81.71 -26.46
EV to Sales
 8.42 7.98 5.44 8.70 10.16
EV to Free Cash Flow
 13.91 11.16 -122.53 -43.69 -14.03
EV to Operating Cash Flow
 13.58 10.40 39.83 365.21 -24.12
Tangible Book Value Per Share
 11.63 10.76 7.27 8.01 6.40
Shareholders’ Equity Per Share
 12.02 11.19 8.06 8.03 7.20
Tax and Other Ratios
Effective Tax Rate
 0.21 0.03 -0.20 0.10 >-0.01
Revenue Per Share
 9.03 7.53 5.79 3.98 3.06
Net Income Per Share
 0.70 0.47 -0.06 -0.66 -1.46
Tax Burden
 0.79 0.97 1.20 0.90 1.00
Interest Burden
 0.82 1.14 0.10 1.09 1.05
Research & Development to Revenue
 0.21 0.20 0.28 0.36 0.63
SG&A to Revenue
 0.48 0.51 0.54 0.12 0.18
Stock-Based Compensation to Revenue
 0.02 0.05 0.06 0.09 0.10
Income Quality
 7.84 11.92 -16.37 -0.13 0.88
Currency in CNY